X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PFIZER ALKEM LABORATORIES/
PFIZER
 
P/E (TTM) x - 27.1 - View Chart
P/BV x 7.2 4.3 166.6% View Chart
Dividend Yield % 0.6 0.8 80.3%  

Financials

 ALKEM LABORATORIES   PFIZER
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PFIZER
Mar-16
ALKEM LABORATORIES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,5892,724 58.3%   
Low Rs1,2321,611 76.5%   
Sales per share (Unadj.) Rs417.5440.9 94.7%  
Earnings per share (Unadj.) Rs56.348.7 115.6%  
Cash flow per share (Unadj.) Rs64.775.8 85.4%  
Dividends per share (Unadj.) Rs12.7015.00 84.7%  
Dividend yield (eoy) %0.90.7 130.1%  
Book value per share (Unadj.) Rs292.9462.9 63.3%  
Shares outstanding (eoy) m119.5745.75 261.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.9 68.7%   
Avg P/E ratio x25.144.5 56.3%  
P/CF ratio (eoy) x21.828.6 76.2%  
Price / Book Value ratio x4.84.7 102.8%  
Dividend payout %22.630.8 73.2%   
Avg Mkt Cap Rs m168,65399,163 170.1%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m9,1712,758 332.6%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m49,91520,170 247.5%  
Other income Rs m1,645857 191.9%   
Total revenues Rs m51,56121,028 245.2%   
Gross profit Rs m8,4824,310 196.8%  
Depreciation Rs m1,0061,239 81.2%   
Interest Rs m6715 12,896.2%   
Profit before tax Rs m8,4513,923 215.4%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m1,6061,794 89.5%   
Profit after tax Rs m6,7312,228 302.1%  
Gross profit margin %17.021.4 79.5%  
Effective tax rate %19.045.7 41.5%   
Net profit margin %13.511.0 122.1%  
BALANCE SHEET DATA
Current assets Rs m27,06216,299 166.0%   
Current liabilities Rs m15,3247,594 201.8%   
Net working cap to sales %23.543.2 54.5%  
Current ratio x1.82.1 82.3%  
Inventory Days Days6765 101.9%  
Debtors Days Days4126 160.3%  
Net fixed assets Rs m12,6108,622 146.2%   
Share capital Rs m239458 52.3%   
"Free" reserves Rs m34,49020,722 166.4%   
Net worth Rs m35,02721,180 165.4%   
Long term debt Rs m1,21225 4,846.4%   
Total assets Rs m54,38729,137 186.7%  
Interest coverage x13.6755.5 1.8%   
Debt to equity ratio x00 2,930.5%  
Sales to assets ratio x0.90.7 132.6%   
Return on assets %13.67.7 177.6%  
Return on equity %19.210.5 182.7%  
Return on capital %24.919.0 130.9%  
Exports to sales %12.90.1 21,757.1%   
Imports to sales %3.117.5 17.7%   
Exports (fob) Rs m6,46112 53,842.5%   
Imports (cif) Rs m1,5403,526 43.7%   
Fx inflow Rs m6,56352 12,707.3%   
Fx outflow Rs m3,012140 2,151.5%   
Net fx Rs m3,552-88 -4,020.8%   
CASH FLOW
From Operations Rs m7,2593,436 211.2%  
From Investments Rs m1,864-6,991 -26.7%  
From Financial Activity Rs m-9,273-619 1,498.5%  
Net Cashflow Rs m-150-4,174 3.6%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 33.1 7.5 441.3%  
FIIs % 0.0 4.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 23.7 -  
Shareholders   68,381 85,207 80.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SHASUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  UNICHEM LAB  WYETH LTD  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm on Exit Polls; Metal Stocks Rise(Closing)

Indian share markets witnessed buying momentum in today's session after exit polls predicted a BJP victory in Gujarat and Himachal Pradesh.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Using Deposits to Rescue Banks is a Bad Idea; It Needs to Be Nipped in the Bud(Vivek Kaul's Diary)

Dec 11, 2017

The Financial Resolution and Deposit Insurance(FRDI) Bill proposes to do just this.

If You're Not Looking for 'Excitement' but 'Big Returns' from Stocks, This Is for You(The 5 Minute Wrapup)

Dec 7, 2017

One does not have to necessarily invest only in 'exciting' stocks to become wealthy.

Beat Fund Managers at Their Own Game with These Stocks(Smart Contrarian)

Dec 6, 2017

The road to big investment gains passes through this universe.

NASA on Aliens and Bitcoin(The Honest Truth)

Dec 14, 2017

The most hilarious scam that aliens have ever planted on Planet Earth.

A Month To Go, Have You Linked Your Aadhaar?(Outside View)

Dec 4, 2017

PersonalFN tells you how to link Aadhaar to to various documents and services.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Dec 15, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - PLETHICO PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS